Tag:
Aratana Therapeutics
Latest Headlines
Latest Headlines
Aratana joins biotech IPO queue while Tetraphase takes a haircut
Aratana Therapeutics, which is developing six new treatments for cats and dogs, joined the biotech queue on Wall Street, filing an S-1 indicating a desire to raise $57.5 million in an IPO.
Aratana adds $15M in VC cash for new pet drug deals with biopharmas
A biotech upstart in Kansas City, KS has garnered $15 million in venture cash to fund deals that will take some of the therapies in development for humans and adapt them to the booming market for
